Rize Oncology Inc.
Rize Oncology Inc.
Indice CSE:
Devise:
Rize Oncology Inc. is a pharmaceutical company dedicated to developing innovative oncology therapies. With a focus on advancing treatments for soft tissue sarcoma, Rize Oncology aims to make a meaningful impact on patients' lives by Turning the Tide on Metastasis.
Rize Oncology Inc. (RIZE)
SEDAR Information
Information d'entreprise
Addresse
301-1665 Ellis Street
Kelowna, BC V1Y 2B3
CanadaTéléphone
(514) 796-2640Courriel
Roland@genetether.comURL
https://www.genetether.comDate d’inscription à la cote
Lundi, mars 28, 2022
Agent de transfert
Odyssey Trust CompanyCapitalisation
Capitalisation:
75744674Réservé à l'émission:
17942855Company Officers
Roland Boivin, Chief Executive Officer
Daren Graham, Chairman
James O'Neill, Chief Financial Officer
John Rothman, Chief Scientific Officer
Bulletins
10/01/2025
2025-0106– Changement de Nom et de Symbole - GeneTether Therapeutics Inc. (GTTX)
le 10 janvier/January 2025
GeneTether Therapeutics Inc. (GTTX) has announced a name and symbol change to Rize Oncology Inc. (RIZE)
Shares will begin trading under the new name and symbol and with a new CUSIP number on January 13, 2024.
Disclosure documents are available at www.thecse.com.
